104 related articles for article (PubMed ID: 8070483)
1. Low molecular weight heparin (Fragmin) prevents early reocclusion following femoral artery thrombolysis with rt-PA in rabbits.
Kornowski R; Glikson M; Hasdai D; Chernine A; Ohad D; Battler A
Eur Heart J; 1994 Apr; 15(4):541-6. PubMed ID: 8070483
[TBL] [Abstract][Full Text] [Related]
2. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
Jang IK; Gold HK; Leinbach RC; Fallon JT; Collen D
Circ Res; 1990 Dec; 67(6):1552-61. PubMed ID: 2123135
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of nitroglycerin on arterial rethrombosis after thrombolysis. Results from a rabbit thrombosis model.
Kornowski R; Chernine A; Hasdai D; Ovadia Z; Battler A
Eur Heart J; 1995 Feb; 16(2):177-83. PubMed ID: 7744088
[TBL] [Abstract][Full Text] [Related]
4. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
[TBL] [Abstract][Full Text] [Related]
5. Heparin and the thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis.
Schneider J
Thromb Res; 1991 Dec; 64(6):677-89. PubMed ID: 1798957
[TBL] [Abstract][Full Text] [Related]
6. Does external ultrasound accelerate thrombolysis? Results from a rabbit model.
Kornowski R; Meltzer RS; Chernine A; Vered Z; Battler A
Circulation; 1994 Jan; 89(1):339-44. PubMed ID: 8281667
[TBL] [Abstract][Full Text] [Related]
7. Effects of therapeutic doses of heparin on thrombolysis with tissue-type plasminogen activator in rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Blood; 1990 Nov; 76(10):2030-6. PubMed ID: 2122919
[TBL] [Abstract][Full Text] [Related]
8. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation.
Yasuda T; Gold HK; Leinbach RC; Yaoita H; Fallon JT; Guerrero L; Napier MA; Bunting S; Collen D
Circulation; 1991 Mar; 83(3):1038-47. PubMed ID: 1900221
[TBL] [Abstract][Full Text] [Related]
9. Influence of heparin and systemic lysis on coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary thrombosis.
Martin U; Fischer S; Sponer G
J Am Coll Cardiol; 1993 Sep; 22(3):914-20. PubMed ID: 8354832
[TBL] [Abstract][Full Text] [Related]
10. Reocclusion after thrombolysis: a problem solved by hirudin?
Rübsamen K; Eschenfelder V
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):97-100. PubMed ID: 1773004
[TBL] [Abstract][Full Text] [Related]
11. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin.
Rübsamen K; Hornberger W
Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261
[TBL] [Abstract][Full Text] [Related]
12. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.
Visconte C; Sainte-Marie M; Lorrain J; Millet L; O'Connor SE; Schaeffer P; Herbert JM
J Thromb Haemost; 2004 Apr; 2(4):629-36. PubMed ID: 15102019
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin analogue, beraprost, sustains recanalization duration after thrombolytic therapy in acute myocardial infarction model.
Saito T; Saitoh S; Asakura T; Kanke M; Owada K; Maruyama Y
Int J Cardiol; 1993 Mar; 38(3):225-33. PubMed ID: 8463004
[TBL] [Abstract][Full Text] [Related]
14. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
[TBL] [Abstract][Full Text] [Related]
15. Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.
Uriuda Y; Wang QD; Hatori N; Nordlander R; Sjöquist PO; Mattsson C; Rydén L
J Pharmacol Toxicol Methods; 1998 Mar; 39(2):81-9. PubMed ID: 9694166
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of heparin in a dog model of rethrombosis following pharmacologic thrombolysis.
Voytik S; Badylak SF; Burke S; Klabunde RE; Henkin J; Simmons A
Thromb Haemost; 1990 Nov; 64(3):438-44. PubMed ID: 2128975
[TBL] [Abstract][Full Text] [Related]
17. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
[TBL] [Abstract][Full Text] [Related]
18. Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
Mellott MJ; Connolly TM; York SJ; Bush LR
Thromb Haemost; 1990 Dec; 64(4):526-34. PubMed ID: 2128137
[TBL] [Abstract][Full Text] [Related]
19. A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.
Kohmura C; Gold HK; Yasuda T; Holt R; Nedelman MA; Guerrero JL; Weisman HF; Collen D
Arterioscler Thromb; 1993 Dec; 13(12):1837-42. PubMed ID: 8241105
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol, a novel cyclic AMP phosphodiesterase inhibitor, prevents reocclusion after coronary arterial thrombolysis with recombinant tissue-type plasminogen activator.
Saitoh S; Saito T; Otake A; Owada T; Mitsugi M; Hashimoto H; Maruyama Y
Arterioscler Thromb; 1993 Apr; 13(4):563-70. PubMed ID: 8385480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
